Status:
COMPLETED
Enhanced Kidney Follow-up for AKI Survivors in Care Transitions
Lead Sponsor:
Mayo Clinic
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the ability of education and outpatient kidney care follow-up in order to improve patient knowledge about acute kidney injury (AKI).
Eligibility Criteria
Inclusion
- KDIGO Stage 3 AKI
- Primary care provider at Mayo Rochester.
Exclusion
- Patient with need for dialysis at discharge from hospital or hospice.
- Enrolled in the Primary Care Transition Program.
- Non-English speaking.
- Cognitive impairment.
- Dementia.
- Mini-Cog score of less than 3.
Key Trial Info
Start Date :
August 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2021
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT04505891
Start Date
August 17 2020
End Date
December 21 2021
Last Update
January 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905